Please use this identifier to cite or link to this item:
Title: Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial.
Austin Authors: Russell, Nicholas ;Hoermann, Rudolf;Cheung, Ada S ;Zajac, Jeffrey D ;Grossmann, Mathis 
Affiliation: Medicine (University of Melbourne)
Issue Date: 1-Nov-2022
Publication information: European Journal of Endocrinology 2022
Abstract: Most men undergoing androgen deprivation therapy (ADT) for prostate cancer experience hot flushes. Current treatments have low or limited evidence of efficacy. It is likely that oestradiol depletion is the mediator of these hot flushes, and transdermal oestradiol might be an effective treatment.
DOI: 10.1530/EJE-22-0318
ORCID: 0000-0001-5596-6601
Journal: European Journal of Endocrinology
Start page: 617
End page: 627
PubMed URL: 36806623
ISSN: 1479-683X
Type: Journal Article
Subjects: Estradiol/therapeutic use
Prostatic Neoplasms/drug therapy
Androgen Antagonists/therapeutic use
Androgens/therapeutic use
Hot Flashes/drug therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jun 25, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.